Healthcare

RCCB's Healthcare Group advises healthcare providers, medical practices, and healthcare-related businesses on the legal, regulatory, and business issues that arise in a highly regulated and rapidly evolving industry. We combine transactional, regulatory, and litigation capabilities to deliver practical, business-focused guidance tailored to the operational realities of healthcare organizations.

We support clients across the full lifecycle of their businesses, from formation and growth through strategic transactions, regulatory scrutiny, and dispute resolution. Clients include physicians, group practices, hospitals, ambulatory surgery centers, healthcare facilities, management service organizations, and other healthcare-adjacent businesses navigating complex legal and compliance environments.

RCCB has a strong transactional and regulatory foundation, advising on mergers & acquisitions, joint ventures, private equity, venture and angel investments, governance matters, and a wide range of commercial arrangements. We regularly counsel clients on healthcare compliance, including billing and coding matters, payor contracting, and responses to governmental and commercial investigations. We also advise on emerging issues affecting healthcare operations, including the integration and use of artificial intelligence in clinical and business settings.

Complementing this work, we represent healthcare providers and organizations in disputes, investigations, and proceedings before regulatory and professional boards. We advise on HIPAA and data privacy matters, employment and shareholder disputes, and claims involving professional licensure and governance. With significant litigation experience, we help clients assess risk, manage potential exposure, and pursue practical resolutions that minimize disruption, cost, and reputational impact.

The Healthcare Group works closely with the firm’s corporate, tax, litigation, and regulatory teams to deliver coordinated, efficient solutions. With a growing presence in key healthcare markets, RCCB is positioned to serve clients regionally and nationally with an integrated, team-based approach.

CLIENT EXPERIENCE

Physician-Owned and Multi-Specialty Medical Practices
Healthcare Technology and Digital Health Companies
Life Sciences and Biotechnology Companies
Private Equity Sponsors and Healthcare Portfolio Companies
Hospitals and Health Systems
Ambulatory Surgery Centers and Outpatient Facilities
Behavioral Health and Addiction Treatment Providers
Long-Term Care, Assisted Living, and Senior Care Operators
Veterinary, Dental, and Optometry Practice Platforms
National and Regional Managed Care Companies
Nonprofit Healthcare and Medical Research Organizations

Experience

Healthcare M&A and Strategic Transactions

Represented the founders of a clinical trial and pharmaceutical development consulting and technology company in their exit sale to a private equity-backed international pharma services conglomerate for consideration in excess of $50 million, including cash and rollover equity.

Represented a healthcare technology company in its strategic sale to a large international conglomerate for $140+ million.

Represented a consulting services and software solutions provider in the clinical trial industry in its exit sale to a private equity-backed strategic acquirer for $55 million in cash and rollover equity.

Represented a healthcare company in connection with a leveraged buy-out of the company by a private equity buyer, where the company’s enterprise value was approximately $66.5 million.

Investigated, documented, and closed multiple strategic acquisition transactions and oversaw their integration into business operations, on behalf of a global manufacturer and distributor of dental and medical device products.

Successfully negotiated a joint venture agreement between a major national managed care company and a leading local integrated health system to establish a co-branded, consumer-directed health plan.

Served as the lead attorney for the sale of a major national managed care company’s New Jersey Medicaid business to a regional managed care company.

Developed and negotiated global strategic alliances with leading dealers, Dental Support Organizations, dental laboratories, and dental OEMs, on behalf of a global manufacturer and distributor of dental and medical device products.

Negotiated and implemented a consent order involving a major national managed care company with the U.S. DOJ and the Texas Attorney General, enabling the acquisition of a major managed care company.

Investigated, documented, and closed multiple strategic acquisition transactions, on behalf of a global manufacturer and distributor of dental and medical device products, involving medical and dental infection control products, and oversaw their integration into ongoing business operations.

Represented the shareholders of a chain of medical practices in the sale of the business to a private equity fund specializing in healthcare services.

Successfully negotiated a joint venture agreement between a major national managed care company and a leading local integrated health system to establish a co-branded, consumer-directed health plan.

Played a key role in the sale of a Texas-based managed care company to a major Blues-branded company.

Represented a healthcare services company in connection with its sale to a search fund-backed buyer for approximately $6.85 million-plus rollover equity.

Represented the founders of a hospice care center in connection with the sale of the business for approximately $2.3 million.

Represented an orthopedic medical practice in an expansion to a multidisciplinary practice with ambulatory surgical centers and occupational health centers.

Private Equity and Growth Investments

Represented a network of veterinary hospitals in connection with the purchase of seven veterinary hospitals for approximately $20.5 million and the related $17 million acquisition financing.

Represented a New Jersey-based private equity client operating in the dental space in the formation of the sponsor and related entities, the raising of capital under Rule 506(b), the acquisition of several private dental practices, and the closing of three commercial loans.

Represented an optometry vertical of a business in connection with its capital raising and acquisitions of middle-market optometry practices and corporate governance.

Directed an interdisciplinary team to address corporate governance and risk issues on behalf of a healthcare company, culminating in a leveraged buyout of the company by a private equity buyer and syndicated senior secured credit facility.

Represented a private equity firm and its portfolio companies in the acquisition financing for a university hospital system.

Healthcare Finance and Capital Raising

Represented a healthcare management software company in connection with a credit facility up to $5 million.

Represented a provider of addiction recovery services in obtaining a $5 million secured loan.

Handled all local Pennsylvania matters, including legal opinion letters, in connection with financing aggregating $48 million for two (2) assisted living facilities in Philadelphia and Bethlehem, PA.

Represented a behavioral health software company in connection with several debt and equity investments, including a secured credit facility of up to $5 million.

Represented a biotech company in connection with the company’s bridge note financing of $1 million.

Represented a venture capital fund in connection with a $4.5 million Series A financing of a healthcare IT company.

Represented a privately held healthcare management and solutions company in a $3.5 million secured convertible note financing transaction, the proceeds from which will be used to open and expand company-managed health clinics and for other general corporate purposes.

Represented a U.S. venture capital fund in a $4.5 million Series A lead investment in an Israeli healthcare technology company.

Life Sciences, Biotech, and Pharma Transactions

Directed the cross-functional commercialization of multiple FDA Class II medical devices across four continents; commercialized 12+ medical devices and drugs on behalf of a global manufacturer and distributor of dental and medical device products.

Represented an Israeli-based biotech company in a worldwide license and distribution agreement with a leading Italian pharma company.

Served as counsel and board member of a 501(c)(3) medical research institute that is commercializing medical research through an innovative public-private corporate structure that facilitates commercialization by nonprofits.

Healthcare Real Estate and Facilities

Represented a hospital system in connection with numerous Medical Office Building (MOB) leases throughout the region.

Represented a locally-based healthcare company in connection with a series of leases for mental healthcare facilities throughout the U.S.

Represented the owner of a life science building in connection with the lease and development of a 40,000 (+/-) square foot pharmaceutical R&D facility.

Represented a medical device manufacturer in connection with the lease and development of a 36,000 (+/-) square foot medical device manufacturing facility.

Healthcare Litigation, Investigations & Restructuring Experience

Represented management, officers, directors, employees, and health care representatives in class actions, SEC claims, white collar investigations, and civil claims in state and federal court.

Represented officers and directors of health care companies in civil, quasi-civil, and investigative matters before state and federal agencies, boards, departments, and governments.

Represented nurses, nurse practitioners, dentists, and other health care professionals under investigation and/or facing licensure and disciplinary charges.

Represented pain management physicians facing audits, subpoenas, and investigations pertaining to prescriptions, insurance, reimbursement, and related disputes.

Represented a physician in a federal investigation and civil claims regarding pharmaceutical purchases through the internet and e-commerce.

Served as counsel to a corporate program integrity team, negotiating vendor agreements and programs to reduce provider fraud, waste, and abuse.

Negotiated and implemented multi-state consent orders involving the DOJ, state attorneys general, and healthcare payors.

Represented a cardiology practice in a billing investigation conducted by the U.S. Department of Justice.

Represented an orthopedic practice in a billing fraud investigation by the Office for Civil Rights.

Represented a medical device company in a Medicaid-related investigation.

Represented physicians and medical practices in shareholder disputes and restrictive covenant litigation.

Represented physicians in hospital medical staff investigations and proceedings before the New Jersey State Board of Medical Examiners.

Healthcare Restructuring & Insolvency

Represented more than 160 companies under common ownership with Purdue Pharma in the Chapter 11 cases involving Purdue Pharma and its affiliates.

Represented DIP lenders:

Sun Healthcare Group
Integrated Health Services
Mercy Hospital of Northern New York

Healthcare & Life Sciences Litigation

Represented physicians in their private investment and business disputes, including multi-million-dollar litigation concerning franchises and franchise rights.

Represented whistleblowers in state and federal litigation related to substance abuse center fraud claims.

Represented medical groups in a dispute with national insurance companies regarding reimbursement.

Represented physicians, medical groups, and medical practices in employment defense litigation, including claims of discrimination under state and federal law.

Represented clients facing claims of discrimination by the State of New Jersey Office of Civil Rights.

Represented physicians in disputes with an internet service provider that ranks and reviews physicians based upon patient feedback and complaints.

Obtained an injunction against intellectual property theft and breach of fiduciary duty by cancer researchers on behalf of a major university and healthcare system.

Served as second-chair in a jury trial involving breach of contract and fiduciary duty claims for a major university and healthcare system.

Litigated and successfully resolved multi-jurisdiction patent litigation concerning polymer technologies used in cosmetic nail applications.

Represented a major pharmaceutical company as plaintiff in a five-week bench patent trial in the U.S. District Court for the Southern District of New York.

Represented a regional hospital post-trial following a medical malpractice verdict involving compensatory damages exceeding $100 million.

Successfully defended a software company against claims of infringement, unfair competition, and cybersquatting, resulting in dismissal with no monetary payment.